GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Welcia Holdings Co Ltd (TSE:3141) » Definitions » Debt-to-EBITDA

Welcia Holdings Co (TSE:3141) Debt-to-EBITDA : 2.94 (As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Welcia Holdings Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Welcia Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was 円23,389 Mil. Welcia Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was 円62,578 Mil. Welcia Holdings Co's annualized EBITDA for the quarter that ended in Nov. 2023 was 円29,292 Mil. Welcia Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Nov. 2023 was 2.93.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Welcia Holdings Co's Debt-to-EBITDA or its related term are showing as below:

TSE:3141' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.64   Med: 0.96   Max: 2.01
Current: 2.01

During the past 13 years, the highest Debt-to-EBITDA Ratio of Welcia Holdings Co was 2.01. The lowest was 0.64. And the median was 0.96.

TSE:3141's Debt-to-EBITDA is ranked better than
57.38% of 420 companies
in the Healthcare Providers & Services industry
Industry Median: 2.575 vs TSE:3141: 2.01

Welcia Holdings Co Debt-to-EBITDA Historical Data

The historical data trend for Welcia Holdings Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welcia Holdings Co Debt-to-EBITDA Chart

Welcia Holdings Co Annual Data
Trend Aug14 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.81 1.01 1.26 1.26

Welcia Holdings Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.14 2.64 1.23 2.94 2.97

Competitive Comparison of Welcia Holdings Co's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Welcia Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Welcia Holdings Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Welcia Holdings Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Welcia Holdings Co's Debt-to-EBITDA falls into.



Welcia Holdings Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Welcia Holdings Co's Debt-to-EBITDA for the fiscal year that ended in Feb. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(23215 + 59484) / 65448
=1.26

Welcia Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Nov. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(23389 + 62578) / 29292
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Nov. 2023) EBITDA data.


Welcia Holdings Co  (TSE:3141) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Welcia Holdings Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Welcia Holdings Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Welcia Holdings Co (TSE:3141) Business Description

Traded in Other Exchanges
Address
2-2-15 Outside Kanda, Chiyoda-ku, Tokyo, JPN, 101-0021
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.

Welcia Holdings Co (TSE:3141) Headlines

No Headlines